All In MedTech

Device Trial Radar · NCT06168305

Safety and Effectiveness of GENOSS® DES in Patients With Multivessel Coronary Artery Disease

Safety and Effectiveness of GENOSS® DES (Sirolimus-eluting Coronary Stent System) in Patients With Multivessel Coronary Artery Disease (MVCAD): A Multicenter, Prospective, Observational Study

Last checked: Nov 19, 2026Latest source record: Oct 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

1,000

Planned (sponsor's estimate)

Start

Nov 15, 2023

Primary completion

Feb 28, 2028

Study completion Feb 28, 2028

Sponsor

Lead sponsor
Genoss Co., Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Dec 13, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 19 years

Summary

As written by the sponsor on the registry.

The investigators intend to establish a multicenter prospective observational study by enrolling and tracking patients with multivessel coronary artery disease (MVCAD) using Genoss DES, a device manufactured with pure domestic technology. The study aims to evaluate the efficacy and safety of Genoss DES in MVCAD patients.

Conditions

  • Percutaneous Coronary Intervention
  • Multivessel Coronary Artery Disease

Interventions

  • GENOSS® DES Sirolimus Eluting Coronary Stent SystemDevice

    The GENOSS® DES is L-605 cobalt chromium (CoCr) platform with a strut thickness of 70µm Sirolimus drug with concentration of 1.15µg/mm2 Abluminal biodegradable PLA and PLGA polymers.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Target Lesion Failure (TLF)Time frame: at 12 months after the procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Korea University GURO Hospital

    Seoul, Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.